Your browser doesn't support javascript.
loading
Culture and Process Change as a Priority for Patient Engagement in Medicines Development.
Boutin, Marc; Dewulf, Lode; Hoos, Anton; Geissler, Jan; Todaro, Veronica; Schneider, Roslyn F; Garzya, Vincenzo; Garvey, Andrew; Robinson, Paul; Saffer, Tonya; Krug, Sarah; Sargeant, Ify.
Afiliação
  • Boutin M; National Health Council, Washington, DC, USA.
  • Dewulf L; UCB Biopharma, Brussels, Belgium.
  • Hoos A; Amgen (Europe) GmbH, Zug, Switzerland.
  • Geissler J; European Patients' Academy on Therapeutic Innovation, Brussels, Belgium.
  • Todaro V; Parkinson's Disease Foundation/Clinical Trials Transformation Initiative, New York, NY, USA.
  • Schneider RF; Pfizer Inc, New York, NY, USA.
  • Garzya V; AstraZeneca, Cambridge, United Kingdom.
  • Garvey A; GlaxoSmithKline, Brentford, United Kingdom.
  • Robinson P; Merck Sharp & Dohme Ltd, Hoddesdon, United Kingdom.
  • Saffer T; National Kidney Foundation, Washington, DC, USA.
  • Krug S; CANCER 101 Foundation, Society for Participatory Medicine, Health Collaboratory New York, NY, USA.
  • Sargeant I; Ismedica Ltd, Staffordshire, United Kingdom.
Ther Innov Regul Sci ; 51(1): 29-38, 2017 Jan.
Article em En | MEDLINE | ID: mdl-28232876
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ther Innov Regul Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ther Innov Regul Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos